PubRank

Shao-An Xue

Author PubWeight™ 29.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005 1.86
2 Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008 1.68
3 Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination. Blood 2011 1.55
4 CD3 limits the efficacy of TCR gene therapy in vivo. Blood 2011 1.55
5 Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol 2010 1.38
6 Monoclonal T-cell receptors: new reagents for cancer therapy. Mol Ther 2007 1.34
7 Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci U S A 2009 1.34
8 Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J Mol Med (Berl) 2008 1.28
9 A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection. Proc Natl Acad Sci U S A 2005 1.25
10 Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 2005 1.24
11 Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells. J Immunol 2007 1.15
12 Generation of tumor-specific T-cell therapies. Blood Rev 2005 1.11
13 Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol 2004 1.07
14 Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients. Transplantation 2003 1.04
15 Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. Blood 2011 0.97
16 Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res 2006 0.97
17 Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Cancer Res 2005 0.94
18 Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine. Cancer Immunol Immunother 2011 0.90
19 Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol 2005 0.90
20 Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood 2005 0.89
21 CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR. Eur J Immunol 2007 0.88
22 WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells. Blood Cells Mol Dis 2007 0.85
23 Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus. Oncogene 2002 0.83
24 T-cell receptor gene therapy for cancer: the progress to date and future objectives. Expert Opin Biol Ther 2007 0.82
25 Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy. Expert Opin Biol Ther 2005 0.78
26 A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function. PLoS One 2007 0.76
27 Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design. Mol Med 2007 0.75
28 Burkitt's lymphoma: maximising the use of fine needle aspirates by long-term preservation for diagnosis and research. Trans R Soc Trop Med Hyg 2010 0.75